Complications and thromboembolic events associated with tamoxifen therapy in patients with breast cancer undergoing microvascular breast reconstruction: a systematic review and meta-analysis Rajiv P. ParikhElizabeth B. OdomTerence M. Myckatyn Review 09 February 2017 Pages: 1 - 10
A single-institution experience of salvage therapy for patients with early and locally advanced breast cancer who progress during neoadjuvant chemotherapy Jacques RaphaelThivaher ParamsothySonal Gandhi Review 27 February 2017 Pages: 11 - 19
Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer Joe YeongAye Aye ThikeJabed Iqbal Preclinical study 23 February 2017 Pages: 21 - 35
Co-targeting the HER and IGF/insulin receptor axis in breast cancer, with triple targeting with endocrine therapy for hormone-sensitive disease Ashok ChakrabortyChristos HatzisMichael P. DiGiovanna Preclinical study 24 February 2017 Pages: 37 - 50
Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data Amila OrucevicJohn L. BellRobert E. Heidel Preclinical study Open access 27 February 2017 Pages: 51 - 61
The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer J. S. ThomasA. M. HanbyOn behalf of the SUPREMO Trial Management Group Clinical trial Open access 11 February 2017 Pages: 63 - 69
The influences of peritumoral lymphatic invasion and vascular invasion on the survival and recurrence according to the molecular subtypes of breast cancer Ki-Tae HwangYoung A. KimYoung Jun Chai Clinical trial 13 February 2017 Pages: 71 - 82
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients Briete GoortsThiemo J. A. van NijnattenMarjolein L. Smidt Clinical trial Open access 15 February 2017 Pages: 83 - 91
Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer Linda ZetterlundFuat CelebiogluJan Frisell Clinical trial Open access 17 February 2017 Pages: 93 - 101
Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer Linda Holmstrand ZetterlundJan FrisellFuat Celebioglu Clinical trial Open access 21 February 2017 Pages: 103 - 110
Management of small T1a/b breast cancer by tumor subtype Tanja IgnatovHolm EggemannAtanas Ignatov Clinical trial 23 February 2017 Pages: 111 - 118
Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology EC InwaldO OrtmannM Klinkhammer-Schalke Epidemiology Open access 15 February 2017 Pages: 119 - 130
A polygenic risk score for breast cancer risk in a Taiwanese population Yi-Chen HsiehShih-Hsin TuHung-Yi Chiou Epidemiology 15 February 2017 Pages: 131 - 138
Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients Boyoung ParkJi Yeon SohnEun Sook Lee Epidemiology Open access 15 February 2017 Pages: 139 - 150
Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities Carol A. PariseVincent Caggiano Epidemiology 17 February 2017 Pages: 151 - 158
Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases T. J. A. van NijnattenJ. M. SimonsM. L. Smidt Epidemiology Open access 17 February 2017 Pages: 159 - 166
Oncologist and organizational factors associated with variation in breast cancer multigene testing Tracy A. LieuG. Thomas RayJeanne S. Mandelblatt Epidemiology 21 February 2017 Pages: 167 - 176
High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function Synnøve YndestadEilin AustreidHans Petter Eikesdal Brief Report Open access 17 February 2017 Pages: 177 - 190
Retrospective review of genomic testing in breast cancer: Does it improve outcome? Grady M. GastelumCyrus IqbalPolly Niravath Brief Report 21 February 2017 Pages: 191 - 195
Erratum to: Diagnostic performance of tomosynthesis and breast ultrasonography in women with dense breasts: a prospective comparison study Won Hwa KimJung Min ChangWoo Kyung Moon Erratum 24 February 2017 Pages: 197 - 197
